US Stock MarketDetailed Quotes
ACLS Axcelis Technologies
- 75.025
- -2.445-3.16%
Trading Nov 26 10:56 ET
2.44BMarket Cap11.10P/E (TTM)
77.660High74.500Low114.02KVolume77.660Open77.470Pre Close8.61MTurnover0.36%Turnover Ratio10.10P/E (Static)32.51MShares158.61052wk High2.50P/B2.41BFloat Cap69.35052wk Low--Dividend TTM32.11MShs Float320.000Historical High--Div YieldTTM4.08%Amplitude0.680Historical Low75.467Avg Price1Lot Size
Axcelis Technologies Stock Forum
Sign in to post a comment
$XP Inc (XP.US)$ $Advanced Micro Devices (AMD.US)$ $Concentrix (CNXC.US)$ $Axcelis Technologies (ACLS.US)$ Those Stocks have positive earnings with moderate to good financial reporting. As you already missed Tech Bull in $NVIDIA (NVDA.US)$ , $Palantir (PLTR.US)$ , $Applovin (APP.US)$, you should look for potential stock that can bull like them.
Please do your own research to confirm....
Please do your own research to confirm....
+1
4
2
$Axcelis Technologies (ACLS.US)$ 92.60
It is going to be a challenging year for Axcelis till end of next year.
ST Catania fab expansion has been delayed and this is going to affect ACLS greatly.
Business is not gaining traction in Europe except in Bosch,Germany. Things are looking bleak for ACLS Europe.
i would not consider buying this stock with a pole. There are other better buys out there to consider such as ASML
It is going to be a challenging year for Axcelis till end of next year.
ST Catania fab expansion has been delayed and this is going to affect ACLS greatly.
Business is not gaining traction in Europe except in Bosch,Germany. Things are looking bleak for ACLS Europe.
i would not consider buying this stock with a pole. There are other better buys out there to consider such as ASML
Semiconductor Equipment up 3.52% making it the top gainer in the US market today.
Notable companies on that list:
$Trio-Tech International (TRT.US)$![]()
5.03%
$Applied Materials (AMAT.US)$![]()
4.25%
$Camtek (CAMT.US)$![]()
4.03%
$Axcelis Technologies (ACLS.US)$![]()
3.79%
$ASML Holding (ASML.US)$![]()
3.71%
$inTEST (INTT.US)$![]()
3.52%
$Amtech Systems (ASYS.US)$![]()
3.42%
Click here for Top Trending Posts
Notable companies on that list:
$Trio-Tech International (TRT.US)$
$Applied Materials (AMAT.US)$
$Camtek (CAMT.US)$
$Axcelis Technologies (ACLS.US)$
$ASML Holding (ASML.US)$
$inTEST (INTT.US)$
$Amtech Systems (ASYS.US)$
Click here for Top Trending Posts
2
$Axcelis Technologies (ACLS.US)$ This is one of the portfolio stock for the long term, but it will be attractive @$90-95. I shall wait for my target.
My research and analysis are not advice or recommendations. It's for information and knowledge purposes only. Any research , analysis, information, or other material received should not be construed as individualized investment advice. Investment decisions should be made as part o...
My research and analysis are not advice or recommendations. It's for information and knowledge purposes only. Any research , analysis, information, or other material received should not be construed as individualized investment advice. Investment decisions should be made as part o...
2
Morning mooers! It is Wednesday, the market is open and chugging away. My name is Kevin Travers, the air quality in the New York Metro Area is making me wheeze, here are stories heard on a Wall Street today.
(I took a boat trip on memorial day lol)
$ASML Holding (ASML.US)$ was the highest gainer on the Nasdaq 100, up 6% after a Jefferies analyst upgrade pointed to hopefully a partnership between ASML and $Taiwan Semiconductor (TSM.US)$,...
(I took a boat trip on memorial day lol)
$ASML Holding (ASML.US)$ was the highest gainer on the Nasdaq 100, up 6% after a Jefferies analyst upgrade pointed to hopefully a partnership between ASML and $Taiwan Semiconductor (TSM.US)$,...
44
3
Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
$Datadog (DDOG.US)$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies (ACLS.US)$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
$Datadog (DDOG.US)$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies (ACLS.US)$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
6
The addition of Graves and Sayiner to the Axcelis board is expected to be beneficial due to their combined experience in semiconductor technology, strategy, and business development. Their contributions are anticipated to lead Axcelis to the next level of growth.
The increasing ROCE and growing capital base are positive signs for Axcelis Technologies, indicating that the company is effectively reinvesting its earnings. This trend is expected to continue, which could lead to further growth in the future.
Axcelis Technologies' earnings growth over the past five years has boosted its market reputation. Despite a recent slowdown in share price growth, its consistent performance makes it a stock to keep an eye on.
Axcelis Technologies is undervalued, suggesting a buying opportunity. The company's expected profit growth isn't fully reflected in the share price. Consider financial health before investing.
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...
Steven J : I bought $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$ at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework